Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 339

1.

Prevention of unintended pregnancies by using emergency contraception: the differences between levonorgestrel and ulipristal acetate. A theoretical model using data from a survey on the use of emergency contraception in Spain, 2017.

Lete I, Doval JL, Pérez-Campos E, Alonso MJ, Sellers G, Sánchez-Borrego R.

Gynecol Endocrinol. 2019 Jan 7:1-4. doi: 10.1080/09513590.2018.1559286. [Epub ahead of print]

PMID:
30614295
2.

Engineering polymeric nanocapsules for an efficient drainage and biodistribution in the lymphatic system.

Cordeiro AS, Crecente-Campo J, López-Bouzo B, González SF, de la Fuente M, Alonso MJ.

J Drug Target. 2019 Jan 2:1-52. doi: 10.1080/1061186X.2018.1561886. [Epub ahead of print]

PMID:
30601085
3.

Co-delivery of RNAi and chemokine by polyarginine nanocapsules enables the modulation of myeloid-derived suppressor cells.

Ledo AM, Sasso MS, Bronte V, Marigo I, Boyd BJ, Garcia-Fuentes M, Alonso MJ.

J Control Release. 2018 Dec 26;295:60-73. doi: 10.1016/j.jconrel.2018.12.041. [Epub ahead of print]

PMID:
30593832
4.

A multifunctional drug nanocarrier for efficient anticancer therapy.

Teijeiro-Valiño C, Novoa-Carballal R, Borrajo E, Vidal A, Alonso-Nocelo M, de la Fuente Freire M, Lopez-Casas PP, Hidalgo M, Csaba N, Alonso MJ.

J Control Release. 2019 Jan 28;294:154-164. doi: 10.1016/j.jconrel.2018.12.002. Epub 2018 Dec 8.

PMID:
30529724
5.

Protamine Nanocapsules for the Development of Thermostable Adjuvanted Nanovaccines.

González-Aramundiz JV, Peleteiro M, González-Fernández Á, Alonso MJ, Csaba NS.

Mol Pharm. 2018 Nov 19. doi: 10.1021/acs.molpharmaceut.8b00852. [Epub ahead of print]

PMID:
30375877
6.

Protamine nanocapsules as carriers for oral peptide delivery.

Thwala LN, Delgado DP, Leone K, Marigo I, Benetti F, Chenlo M, Alvarez CV, Tovar S, Dieguez C, Csaba NS, Alonso MJ.

J Control Release. 2018 Dec 10;291:157-168. doi: 10.1016/j.jconrel.2018.10.022. Epub 2018 Oct 18.

PMID:
30343137
7.

Influence of the surface properties of nanocapsules on their interaction with intestinal barriers.

Santalices I, Torres D, Lozano MV, Arroyo-Jiménez MM, Alonso MJ, Santander-Ortega MJ.

Eur J Pharm Biopharm. 2018 Dec;133:203-213. doi: 10.1016/j.ejpb.2018.09.023. Epub 2018 Sep 27.

PMID:
30268595
8.

Mucosal antibody responses to vaccines targeting SIV protease cleavage sites or full-length Gag and Env proteins in Mauritian cynomolgus macaques.

Li H, Hai Y, Lim SY, Toledo N, Crecente-Campo J, Schalk D, Li L, Omange RW, Dacoba TG, Liu LR, Kashem MA, Wan Y, Liang B, Li Q, Rakasz E, Schultz-Darken N, Alonso MJ, Plummer FA, Whitney JB, Luo M.

PLoS One. 2018 Aug 28;13(8):e0202997. doi: 10.1371/journal.pone.0202997. eCollection 2018.

9.

Bilayer polymeric nanocapsules: A formulation approach for a thermostable and adjuvanted E. coli antigen vaccine.

Crecente-Campo J, Lorenzo-Abalde S, Mora A, Marzoa J, Csaba N, Blanco J, González-Fernández Á, Alonso MJ.

J Control Release. 2018 Sep 28;286:20-32. doi: 10.1016/j.jconrel.2018.07.018. Epub 2018 Jul 12.

PMID:
30017722
10.

mPGES-1 (Microsomal Prostaglandin E Synthase-1) Mediates Vascular Dysfunction in Hypertension Through Oxidative Stress.

Avendaño MS, García-Redondo AB, Zalba G, González-Amor M, Aguado A, Martínez-Revelles S, Beltrán LM, Camacho M, Cachofeiro V, Alonso MJ, Salaices M, Briones AM.

Hypertension. 2018 Aug;72(2):492-502. doi: 10.1161/HYPERTENSIONAHA.118.10833. Epub 2018 Jun 11.

PMID:
29891646
11.

Polymeric Nanocapsules for Vaccine Delivery: Influence of the Polymeric Shell on the Interaction With the Immune System.

Peleteiro M, Presas E, González-Aramundiz JV, Sánchez-Correa B, Simón-Vázquez R, Csaba N, Alonso MJ, González-Fernández Á.

Front Immunol. 2018 Apr 19;9:791. doi: 10.3389/fimmu.2018.00791. eCollection 2018.

12.

PEG-PGA enveloped octaarginine-peptide nanocomplexes: An oral peptide delivery strategy.

Niu Z, Samaridou E, Jaumain E, Coëne J, Ullio G, Shrestha N, Garcia J, Durán-Lobato M, Tovar S, Santander-Ortega MJ, Lozano MV, Arroyo-Jimenez MM, Ramos-Membrive R, Peñuelas I, Mabondzo A, Préat V, Teixidó M, Giralt E, Alonso MJ.

J Control Release. 2018 Apr 28;276:125-139. doi: 10.1016/j.jconrel.2018.03.004. Epub 2018 Mar 6.

PMID:
29518466
13.

Determination of free formaldehyde in cosmetics containing formaldehyde-releasing preservatives by reversed-phase dispersive liquid-liquid microextraction and liquid chromatography with post-column derivatization.

Miralles P, Chisvert A, Alonso MJ, Hernandorena S, Salvador A.

J Chromatogr A. 2018 Mar 30;1543:34-39. doi: 10.1016/j.chroma.2018.02.031. Epub 2018 Feb 20.

PMID:
29478830
14.

Mercury-induced vascular dysfunction is mediated by angiotensin II AT-1 receptor upregulation.

Rizzetti DA, da Silva TM, Escobar AG, Piagette J, Peçanha FM, Vassallo DV, Alonso MJ, Salaices M, Wiggers GA.

Environ Res. 2018 Apr;162:287-296. doi: 10.1016/j.envres.2018.01.026. Epub 2018 Feb 4.

PMID:
29407760
15.

Nose-to-brain peptide delivery - The potential of nanotechnology.

Samaridou E, Alonso MJ.

Bioorg Med Chem. 2018 Jun 1;26(10):2888-2905. doi: 10.1016/j.bmc.2017.11.001. Epub 2017 Nov 4. Review.

PMID:
29170026
16.

Modulating the immune system through nanotechnology.

Dacoba TG, Olivera A, Torres D, Crecente-Campo J, Alonso MJ.

Semin Immunol. 2017 Dec;34:78-102. doi: 10.1016/j.smim.2017.09.007. Epub 2017 Oct 9. Review.

17.

Natural and cross-inducible anti-SIV antibodies in Mauritian cynomolgus macaques.

Li H, Nykoluk M, Li L, Liu LR, Omange RW, Soule G, Schroeder LT, Toledo N, Kashem MA, Correia-Pinto JF, Liang B, Schultz-Darken N, Alonso MJ, Whitney JB, Plummer FA, Luo M.

PLoS One. 2017 Oct 5;12(10):e0186079. doi: 10.1371/journal.pone.0186079. eCollection 2017.

18.

Targeting tumor associated macrophages: The new challenge for nanomedicine.

Andón FT, Digifico E, Maeda A, Erreni M, Mantovani A, Alonso MJ, Allavena P.

Semin Immunol. 2017 Dec;34:103-113. doi: 10.1016/j.smim.2017.09.004. Epub 2017 Sep 21. Review.

PMID:
28941641
19.

Aluminum exposure at human dietary levels promotes vascular dysfunction and increases blood pressure in rats: A concerted action of NAD(P)H oxidase and COX-2.

Martinez CS, Piagette JT, Escobar AG, Martín Á, Palacios R, Peçanha FM, Vassallo DV, Exley C, Alonso MJ, Miguel M, Salaices M, Wiggers GA.

Toxicology. 2017 Sep 1;390:10-21. doi: 10.1016/j.tox.2017.08.004. Epub 2017 Aug 19.

PMID:
28826906
20.

Assessment of the permeability and toxicity of polymeric nanocapsules using the zebrafish model.

Teijeiro-Valiño C, Yebra-Pimentel E, Guerra-Varela J, Csaba N, Alonso MJ, Sánchez L.

Nanomedicine (Lond). 2017 Sep;12(17):2069-2082. doi: 10.2217/nnm-2017-0078. Epub 2017 Aug 14.

PMID:
28805098

Supplemental Content

Loading ...
Support Center